Invuity Announces Proposed Public Offering of Common Stock
March 14 2018 - 4:04PM
Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading
medical technology company focused on minimal access surgery, today
announced that it intends to offer and sell, subject to market and
other conditions, shares of its common stock in an underwritten
public offering. Invuity expects to grant the underwriters a 30-day
option to purchase additional shares of its common stock.
Invuity intends to use the net proceeds from the offering for
continued expansion of its sales and marketing activities, working
capital and other general corporate purposes.
William Blair & Company, L.L.C. is acting as the sole
book-running manager for the offering.
The offering is being made pursuant to an effective shelf
registration statement on Form S-3 (No. 333-212395) that was
initially filed with the U.S. Securities and Exchange Commission
(the "SEC") on July 1, 2016. A preliminary prospectus supplement
describing the terms of the offering will be filed with the SEC and
will form a part of the effective registration statement and will
be available on the SEC's website located at www.sec.gov. When
available, copies of the preliminary prospectus supplement and the
accompanying prospectus relating to the offering may be obtained
from the offices of William Blair & Company, L.L.C., Attention:
Prospectus Department, 150 North Riverside Plaza, Chicago, IL
60606; Telephone: (800) 621-0687 or by email at
prospectus@williamblair.com.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on
developing and marketing advanced surgical devices to improve the
ability of physicians to perform minimal access surgery through
smaller and hidden incisions. The Company's patented Intelligent
Photonics® technology delivers enhanced visualization, which
facilitates surgical precision, efficiency and safety.
Clinical applications include women’s health, encompassing
breast cancer and breast reconstruction surgery, gynecology and
thyroid surgery. Additional applications include procedures
for electrophysiology, spine, orthopedic, cardiothoracic and
general surgery. Invuity is headquartered in San Francisco,
CA.
Forward-Looking Statements
This announcement contains forward-looking statements within the
meaning of the Securities Act of 1933, as amended, the Securities
Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995. These forward-looking statements,
including statements regarding the proposed public offering and the
anticipated use of proceeds therefrom, are subject to a number of
risks and uncertainties which may cause actual results or outcomes
to be materially different from those expressed or implied by the
forward-looking statements. These risks and uncertainties include
market risks and uncertainties and risks and uncertainties relating
to the satisfaction of customary closing conditions for an
underwritten offering of securities, as well as the risks and
uncertainties that could affect the Company's business and
financial results described in the preliminary prospectus
supplement and registration statement referenced above, as well as
the Company’s other filings with the SEC, including, without
limitation, under the caption "Risk Factors." There can be no
assurance that the Company will be able to complete the proposed
public offering on the anticipated terms, or at all.
Forward-looking statements relate only to events as of the date on
which the statements are made, and the Company undertakes no
obligation to publicly update or review any forward-looking
statement.
CONTACT:
Company Contact: Jim Mackaness Chief Financial Officer Invuity,
Inc. 415-655-2129
Investors: Mark Klausner Westwicke Partners 443-213-0501
irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jun 2024 to Jul 2024
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jul 2023 to Jul 2024